Predictive Oncology Inc.

NASDAQ: POAI
Share price (8/20/25): $0.90
Market cap (8/20/25): $9.803 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 62 pages Agreement and Plan of Merger by and Among Zpredicta, Inc. Golden Gate Acquisition Inc. Predictive Oncology Inc. and Tom Kelly, as Company Interest Representative Dated as of November 24, 2021 Agreement and Plan of Merger

from 8-K 33 pages Asset Purchase Agreement

from 8-K 25 pages Asset Purchase Agreement

from 425 73 pages Amended and Restated Agreement and Plan of Merger by and Among Precision Therapeutics Inc., Helomics Acquisition, Inc., Helomics Holding Corporation and Gerald J. Vardzel, Jr., as Stockholder Representative Dated as of October 22, 2018

from 8-K 73 pages Amended and Restated Agreement and Plan of Merger by and Among Precision Therapeutics Inc., Helomics Acquisition, Inc., Helomics Holding Corporation and Gerald J. Vardzel, Jr., as Stockholder Representative Dated as of October 22, 2018

from 8-K 73 pages Agreement and Plan of Merger by and Among Precision Therapeutics Inc., Helomics Acquisition, Inc., Helomics Holding Corporation and Gerald J. Vardzel, Jr., as Stockholder Representative Dated as of June 28, 2018

from 8-K 89 pages Agreement and Plan of Merger by and Among Skyline Medical Inc. Skyline Cyto Acquisition, Inc., Cytobioscience, Inc., and Alan Dean, as Stockholder Representative Dated as of August 9, 2017

from 8-K 5 pages Agreement and Plan of Merger